Approval · Notice of Compliance 23012 · 2019
ERLEADA: Notice of Compliance 23012
Issued December 12, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23012
- Date
- December 12, 2019
- Company
- Janssen Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Priority
- Reason
- New indication
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ERLEADA | Not yet assigned | — |
Medicinal ingredients
- APALUTAMIDE 60 MG per TAB